Cargando…

First-in-man Safety and Efficacy of the Adipose Graft Transposition Procedure (AGTP) in Patients With a Myocardial Scar

BACKGROUND: The present study evaluates the safety and efficacy of the Adipose Graft Transposition Procedure (AGTP) as a biological regenerative innovation for patients with a chronic myocardial scar. METHODS: This prospective, randomized single-center controlled study included 10 patients with esta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bayes-Genis, Antoni, Gastelurrutia, Paloma, Cámara, Maria-Luisa, Teis, Albert, Lupón, Josep, Llibre, Cinta, Zamora, Elisabet, Alomar, Xavier, Ruyra, Xavier, Roura, Santiago, Revilla, Ana, San Román, José Alberto, Gálvez-Montón, Carolina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4909363/ https://www.ncbi.nlm.nih.gov/pubmed/27322478 http://dx.doi.org/10.1016/j.ebiom.2016.03.027

Ejemplares similares

Electrophysiological effects of adipose graft transposition procedure (AGTP) on the post-myocardial infarction scar: A multimodal characterization of arrhythmogenic substrate
por: Adeliño, Raquel, et al.
Publicado: (2022)

Rationale and design of a multicentre, prospective, randomised, controlled clinical trial to evaluate the efficacy of the adipose graft transposition procedure in patients with a myocardial scar: the AGTP II trial
por: Gastelurrutia, Paloma, et al.
Publicado: (2017)

Our Journey Through Advanced Therapies to Reduce Post-Infarct Scarring
por: Roura, Santiago, et al.
Publicado: (2021)

Limited Value of Cystatin-C over Estimated Glomerular Filtration Rate for Heart Failure Risk Stratification
por: Zamora, Elisabet, et al.
Publicado: (2012)

Bioluminescence imaging: a shining future for cardiac regeneration
por: Roura, Santiago, et al.
Publicado: (2013)

Transitioning From Preclinical Evidence to Advanced Therapy Medicinal Product: A Spanish Experience
por: Gastelurrutia, Paloma, et al.
Publicado: (2021)

Determination of HLA‐A, ‐B, ‐C, ‐DRB1 and ‐DQB1 allele and haplotype frequencies in heart failure patients
por: Roura, Santiago, et al.
Publicado: (2019)

The role and potential of umbilical cord blood in an era of new therapies: a review
por: Roura, Santiago, et al.
Publicado: (2015)

Impact of Umbilical Cord Blood-Derived Mesenchymal Stem Cells on Cardiovascular Research
por: Roura, Santiago, et al.
Publicado: (2015)

Mesenchymal stem cells for cardiac repair: are the actors ready for the clinical scenario?
por: Roura, Santiago, et al.
Publicado: (2017)

Circulating monocyte subsets and heart failure prognosis
por: Elchinova, Elena, et al.
Publicado: (2018)

Long COVID-19 and microvascular disease-related angina
por: Vallejo Camazón, Nuria, et al.
Publicado: (2022)

COVID-19 persistente y angina microvascular
por: Vallejo Camazón, Nuria, et al.
Publicado: (2022)

Nutritional Status According to the GLIM Criteria in Patients with Chronic Heart Failure: Association with Prognosis
por: Joaquín, Clara, et al.
Publicado: (2022)

Telomere attrition in heart failure: a flow-FISH longitudinal analysis of circulating monocytes
por: Teubel, Iris, et al.
Publicado: (2018)

Potential role for clinical calibration to increase engagement with and application of home telemonitoring: a report from the HeartCycle programme
por: Gastelurrutia, Paloma, et al.
Publicado: (2016)

Mesenchymal Stem Cells Induce Expression of CD73 in Human Monocytes In Vitro and in a Swine Model of Myocardial Infarction In Vivo
por: Monguió-Tortajada, Marta, et al.
Publicado: (2017)

Extracellular vesicles do not contribute to higher circulating levels of soluble LRP1 in idiopathic dilated cardiomyopathy
por: Roura, Santiago, et al.
Publicado: (2017)

Preclinical Evaluation of the Immunomodulatory Properties of Cardiac Adipose Tissue Progenitor Cells Using Umbilical Cord Blood Mesenchymal Stem Cells: A Direct Comparative Study
por: Perea-Gil, Isaac, et al.
Publicado: (2015)

Epigenetic Biomarkers in Cardiovascular Diseases
por: Soler-Botija, Carolina, et al.
Publicado: (2019)

Deep Learning Analyses to Delineate the Molecular Remodeling Process after Myocardial Infarction
por: Iborra-Egea, Oriol, et al.
Publicado: (2021)

Noninvasive Assessment of an Engineered Bioactive Graft in Myocardial Infarction: Impact on Cardiac Function and Scar Healing
por: Gálvez‐Montón, Carolina, et al.
Publicado: (2016)

Local administration of porcine immunomodulatory, chemotactic and angiogenic extracellular vesicles using engineered cardiac scaffolds for myocardial infarction
por: Monguió-Tortajada, Marta, et al.
Publicado: (2021)

Impact of Frailty on Mortality and Hospitalization in Chronic Heart Failure: A Systematic Review and Meta‐Analysis
por: Yang, Xiaobo, et al.
Publicado: (2018)

Mechanisms of action of sacubitril/valsartan on cardiac remodeling: a systems biology approach
por: Iborra-Egea, Oriol, et al.
Publicado: (2017)

Development of a Novel Heart Failure Risk Tool: The Barcelona Bio-Heart Failure Risk Calculator (BCN Bio-HF Calculator)
por: Lupón, Josep, et al.
Publicado: (2014)

Can Natriuretic Peptides be Used to Guide Therapy?
por: Bayes-Genis, Antoni, et al.
Publicado: (2016)

Acellular cardiac scaffolds enriched with MSC-derived extracellular vesicles limit ventricular remodelling and exert local and systemic immunomodulation in a myocardial infarction porcine model
por: Monguió-Tortajada, Marta, et al.
Publicado: (2022)

Unravelling the effects of mechanical physiological conditioning on cardiac adipose tissue-derived progenitor cells in vitro and in silico
por: Llucià-Valldeperas, Aida, et al.
Publicado: (2018)

Author Correction: Unravelling the effects of mechanical physiological conditioning on cardiac adipose tissue-derived progenitor cells in vitro and in silico
por: Llucià-Valldeperas, Aida, et al.
Publicado: (2018)

Impact of a ‘stent for life’ initiative on post‐ST elevation myocardial infarction heart failure: a 15 year heart failure clinic experience
por: Bayes‐Genis, Antoni, et al.
Publicado: (2017)

Comorbidities, Fragility, and Quality of Life in Heart Failure Patients With Midrange Ejection Fraction
por: Gastelurrutia, Paloma, et al.
Publicado: (2018)

Treatment of cardiac fibrosis: from neuro-hormonal inhibitors to CAR-T cell therapy
por: Morfino, Paolo, et al.
Publicado: (2022)

First-in-human PeriCord cardiac bioimplant: Scalability and GMP manufacturing of an allogeneic engineered tissue graft
por: Prat-Vidal, Cristina, et al.
Publicado: (2020)

Persistent chest pain after recovery of COVID-19: microvascular disease-related angina?
por: Vallejo, Nuria, et al.
Publicado: (2021)

Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Promote Vascular Growth In Vivo
por: Roura, Santiago, et al.
Publicado: (2012)

Are mesenchymal stem cells and derived extracellular vesicles valuable to halt the COVID-19 inflammatory cascade? Current evidence and future perspectives
por: Monguió-Tortajada, Marta, et al.
Publicado: (2021)

Lung ultrasound and biomarkers in primary care: Partners for a better management of patients with heart failure?
por: Domingo, Mar, et al.
Publicado: (2020)

Sacubitril/valsartan affects pulmonary arterial pressure in heart failure with preserved ejection fraction and pulmonary hypertension
por: Codina, Pau, et al.
Publicado: (2022)

Physiological conditioning by electric field stimulation promotes cardiomyogenic gene expression in human cardiomyocyte progenitor cells
por: Llucià-Valldeperas, Aida, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_219lajo7u2taiu2nt5pbpa2hfs